Direct single gene mutational events account for radiation-induced intestinal adenoma yields in Apc(Min/+) mice

Michele Ellender1, John D Harrison, Alan A Edwards

  • 1National Radiological Protection Board, Chilton, Didcot, Oxon, OX11 ORQ, United Kingdom. michele.ellender@nrpb.org

Radiation Research
|April 27, 2005
PubMed

Insights

X radiation induces small intestinal tumors in Apc(Min/+) mice. Loss of the Apc+ gene is sufficient for adenoma initiation, without requiring genomic instability.

Area of Science:

  • Oncology
  • Genetics
  • Radiation Biology

Background:

  • Apc(Min/+) mice are a model for intestinal adenoma development.
  • X radiation is known to induce mutations and tumors.

Purpose of the Study:

  • To investigate the role of X radiation in inducing small intestinal tumors in Apc(Min/+) mice.
  • To determine if direct gene mutation or genomic instability drives adenoma initiation.

Main Methods:

  • Induction of tumors using X radiation in Apc(Min/+) mice.
  • Comparison of tumor incidence with literature data on radiation-induced mutation frequencies.

Main Results:

  • X radiation induced small intestinal tumors, primarily adenomas.
  • The incidence of radiation-induced adenomas supports the hypothesis that loss of Apc+ is sufficient for initiation.
  • Adenoma initiation rates were comparable to or lower than direct somatic gene mutation frequencies.

Conclusions:

  • Direct mutational loss of Apc+ is the sole requirement for intestinal adenoma initiation in this model.
  • Genomic instability is not necessary for adenoma initiation, though it may play a role in tumor progression.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Mutations01:39

Mutations

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.